Ciox Health, the nation’s leader in health information management and data exchange, announced today the appointment of Paul Roma as chief executive officer, effective immediately. Mr. Roma joins Ciox from Deloitte LLP, where he was chief analytics officer and led the Deloitte Analytics division. Mr. Roma succeeds Ed Coleman, who will remain actively engaged with Ciox as a member of the board of directors.
“It is my pleasure to welcome Paul Roma to Ciox as our new CEO, and I believe he is ideally suited to lead Ciox as we continue to advance the vision for technology-enabled clinical data exchange and interoperability in the U.S.,” said Mr. Coleman. “We expect to benefit from Paul’s deep domain knowledge and broad experience serving healthcare providers, health plans and patients over many years. This, coupled with his exceptional record in effecting large-scale transformations for customers navigating the changing dynamics of the modern healthcare ecosystem, will accelerate the Company’s ability to serve as an essential partner to our customers.”
While at Deloitte, Mr. Roma’s responsibilities included addressing some of the most challenging problems in healthcare through extensive work with healthcare providers, health plans, life sciences companies and government agencies. He has significant experience in building and leading large teams and growing software-based businesses that leverage the cloud and deliver results on a global scale. Mr. Roma is an expert in assisting all segments of the healthcare ecosystem augment human care with technology to better serve patients and improve outcomes for all constituents.
“I look forward to joining and leading the team of talented and passionate employees at Ciox,” said Mr. Roma. “At a time when the demand for clinical data is growing rapidly, the Company is playing an increasingly pivotal role by enabling compliant access and interoperability. Ciox has built relationships with many of the key constituents in the healthcare landscape, and I believe we are positioned for exceptional growth by enabling those customers to more effectively share and derive valuable insights from clinical information. I am excited to be a part of such a dynamic company at a critical inflection point in its history.”
“The addition of Paul Roma to the executive team further elevates the strategic and operational strengths of Ciox and will help drive continued innovation and growth at the Company,” said Matt Holt, chairman of the Ciox Board of Directors and a managing director at New Mountain Capital. “We all thank Ed for his outstanding leadership over the past year and we look forward to his involvement and contributions on the Board going forward.”